#14 on Breakout Boards!!


GLTA!

Way to continue viewing the glass as half full sharpei! The board SP should watch and learn.


GLTA!

"Capt. Amos Burke: When the track's muddy, and you're trying to get even, never walk away from a long shot: Burke's Law."

Sounds like you are a man of action. Here is Joseph Kristul CEO's cell phone
415-317-3620. Willing to bet you can rattle his cage. He doesn't talk to me but I am certain he will talk to THE MAN BEHIND THE ART OF THE DEAL!

Who knows but while you're at it, and with your great power of persuasion, you can get HCTI to PAY FOR THE WALL.



GLTA!

PRESS RELEASE
Tauriga Sciences Inc. Actively Evaluating Potential Blockchain Opportunities

Published: Jan 17, 2018 1:59 p.m. ET


NEW YORK, NY, Jan 17, 2018 (GLOBE NEWSWIRE via COMTEX) --

Tauriga Sciences, Inc. (otc pink:TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that the Company is now actively evaluating potential opportunities relating to Blockchain technologies and applications.

On January 4, 2018, the Company announced that its Board of Directors ("BOD") had voted unanimously in favor of the formation a wholly owned subsidiary focused on acquiring interest(s) in patents and other intellectual property pertaining to Blockchain technology ("Blockchain"). This subsidiary, which was incorporated in Delaware, was named "Tauriga IP Acquisition Corp." and received financial commitment(s) of up to $300,000 USD from Tauriga's available cash position.

Tauirga's CEO Seth M. Shaw expressed, "The Company formed a wholly owned subsidiary earlier this month, in order to be structurally prepared to capitalize on potentially valuable opportunities. Management is now actively evaluating several potential opportunities pertaining to Blockchain and is hopeful to consummate one or more transactions in that sector, should the due diligence process prove satisfactory. The Company believes that it is continuing to make meaningful progress with respect to a number of important corporate initiatives.

There can be no guarantees that the Company will determine that any of the potential opportunity under evaluation is worthy of acquisition or investment, or that the Company will ultimately acquire Blockchain technologies at all.

ABOUT TAURIGA SCIENCES, INC.

Tauriga Sciences, Inc. (OTC PINK: TAUG ) is engaged in building business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities/equity investments. The Company is presently focused on its upcoming contemplated launch of a Cupacu Butter based lip balm product branded under the name: Herman. The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. Please visit our corporate website at www.tauriga.com

FORWARD-LOOKING STATEMENTS:

This press release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995 which represent management's beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as "may," "will," "expects," "anticipates," believes, "hopes," "believes," or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management's present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the "Risk Factors" section of Tauriga's Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

CONTACT INFORMATION: Tauriga Sciences, Inc. 555 Madison Avenue, 5th Floor New York, NY 10022 Chief Executive Officer Mr. Seth M. Shaw Email: sshaw@tauriga.com cell # (917) 796 9926 www.tauriga.com
Copyright (C) 2018 GlobeNewswire, Inc. All rights reserved.

https://www.marketwatch.com/story/tauriga-sciences-inc-actively-evaluating-potential-blockchain-opportunities-2018-01-17?siteid=nbsh

"No bid again, and Management should have updated license by now IMO. Seems like they are slacking on purpose."


In 100% agreement with you pal.


Tell you what....since your hero is the undisputed greatest deal maker of out time why not take a page from his book and call HCTI at 650-491-3449 and make them an offer they can't refuse. And while you're at it maybe you can get them to PAY FOR THE WALL.



GLTA!

According to Darin Nellis HCTI will issue financials in good time.



GLTA!

"Cannot wait to see what this week has to offer"

One thing is for sure.....it won't be dull around here.



GLTA!

Three cheers for HCTI

Home of one of the finest potential technologies to be found on the OTC.
Home of some of the finest Due Diligence individuals to be found anywhere.
Home of opportunity and hope that this investment could be life changing for many.
Home of the sociopath as there are always several in these kind of investments.


Time to Rock it from the Delta to the DMZ!!!!!!

GLTA!

http://ih.advfn.com/stock-market/USOTC/hybrid-coating-technologies-HCTI/trades

Are my eyes deceiving me or do we actually have a bid? YIPPEE!!!!!!!!!

Time to Rock it from the Delta to the DMZ!!!!!!


GLTA!

"Also It's management's turn to give back to the loyal Longterm shareholders for their support."

Hope you are right. The fact is management has rarely (if ever) shown respect for the loyal Longterm shareholders so this would be a well overdue and well deserved. IMHO



GLTA!

It is hard to know where the stock price is heading without financials. Should HCTI be generating some decent revenues and should management decide to make some insider buys anything is possible. There are billions of shares controlled by a very few so despite the dire predictions by some this stock could take off with the right rocket fuel.

Let's wait to see what HCTI management brings to the table after issuance of the Newsletter.


GLTA!

Agreed Karma11. We could launch at any time!


GLTA!

Nice volume today.

Muy bien Señora!

Take 2 and go to left.

PRESS RELEASE
Tauriga Sciences, Inc. Announces the Relocation of its Corporate Headquarters to Midtown Manhattan

Published: Nov 29, 2017 8:00 a.m. ET


NEW YORK, NY, Nov 29, 2017 (Marketwired via COMTEX) -- NEW YORK, NY--(Marketwired - Nov 29, 2017) - Tauriga Sciences, Inc. (otc pink:TAUG) ("Tauriga" or the "Company") today announced that it has decided to move its corporate headquarters from Danbury, Connecticut to Midtown Manhattan in New York City. The effective date of this relocation will be December 1, 2017.

Tauriga is pleased to announce that the following address will serve as its new Corporate Headquarters:

Tauriga Sciences Inc. Attn: Seth M. Shaw (Chief Executive Officer) 555 Madison Avenue, 5th Floor New York NY 10022 Tel. (917)-796-9926

The Company has entered into a 24 month lease for the above-mentioned address, commencing December 1, 2017 and will be paying exactly $1,010 per month for the term of the lease.

ABOUT TAURIGA SCIENCES, INC.
See Also
The Moneyist: When your partner wants to live with you for free

Tauriga Sciences, Inc. (otc pink:TAUG) is engaged in building life sciences company through the development, marketing, distribution and potential licensing of a broad array of products and technologies. The Company is presently focused on its upcoming contemplated launch of a Cupacu Butter based lip balm product branded under the name: Herman. The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. Please visit the Corporate Website at www.tauriga.com

NON SOLICITATION:

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.

DISCLAIMER:

Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission.

Contact Info: Mr. Seth M. Shaw Chief Executive Officer Tauriga Sciences Inc. Cell # 917-796-9926 Email: sshaw@tauriga.com Website: www.tauriga.com

2017 Nasdaq, Inc. All rights reserved.

Let's hope you are right.

You know what they say........From your lips to..... and IMHO

Any thoughts on HCTI? Has been no bid now for quite a while. Appears to have some rather compelling technology. Much appreciated!

Once again, you are 100% correct. Happy Thanksgiving!

"All we need is financials and some good PR." Is that all we need? Piece of cake.

Seth will make us a bleeping fortune.

Everything else is noise.

Now that's what I'm talking about.

Thanks sharpei

As someone who actually owns shares in HCTI, this shareholder believes you are correct and it is more than likely we will hear something in the not too distant future IMHO.

Thank you sharpei!

Great Post! You make all the sense in the world gonefishin1 and in your camp 100%. Only a matter of time before HCTI breaks out! Watch those revenues flow soon!



$HCTI

What if the tireless efforts of one Seth Shaw pay off big time and make TAUG investors wealthy?


SETH SHAW IS OUR MAN! IF SETH CAN'T DO IT NO ONE CAN!


$TAUG

Just giving credit where credit was due..........
MY MAN!!!!!...........

Now DD complete.










Only due diligence needed is Kristul is involved.

No volume, no bid, no emails / phone answered,
and no required filings.

DD complete.

Most thought provoking due diligence question possibly ever posed here. Certainly as far back as can be remembered. Incredible job... CONGRATULATIONS!!!!!!!!!

Please keep that priceless DD coming....JMHO.










Is this the first zero volume day we've had?

Let's give credit where credit is due. When one has made a major $100 (plus commission) investment one should post at least several times a day to keep the company on it's toes. After all it's all about ROI! We should all be grateful. I know I am.

SETH SHAW HE'S OUR MAN....IF SETH CAN'T DO IT NO ONE CAN!!!!!!!!
WE BELIEVE IN YOU SETH!!!!!!!!!

Looking forward to a jury trial. The verdict should be one for the ages. If there are punitive damages
stipulated in the court's decision just wondering how many millions may be expected.


$TAUG

Unable to enter order because orders for Bulletin Board, Pink Sheet and Foreign ADR/ORD securities must be placed as limit orders.

Come on gonefishin1, you shouldn't be calling out ba who knows all.

SETH SHAW IS OUR MAN. IF SETH CAN'T DO IT NO ONE CAN!

TAUG

Excellent post Travis!
And the beat goes on!


HCTI

Seth is our man. If Seth can't do it no one can!


TAUG

So you see HCTI possibly open @ .57 now? Agree 100% with your assessment that HCTI has great potential although .57 might be a tad bit over optimistic at this point.


GREAT CALL THOUGH!

Tauriga Sciences Inc. Discloses Additional Personal Investment of $55,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125

Published: June 21, 2017 1:30 p.m. ET

NEW YORK, NY, Jun 21, 2017 (Marketwired via COMTEX) -- NEW YORK, NY--(Marketwired - Jun 21, 2017) - Tauriga Sciences Inc. (otc pink:TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made an additional personal investment into the Company totaling $55,000 USD at this time. This personal investment was once again structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent"), for a total of 44,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). Including the personal investment disclosed last week ($95,000 USD on June 15, 2017), Mr. Shaw has now invested a total of $150,000 USD into the Company at this price of $0.00125 per share; for a total of 120,000,000 shares. The Company will utilize this infusion of working capital for general and administrative purposes; these 44,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.

ABOUT TAURIGA SCIENCES, INC.

Tauriga Sciences, Inc. (otc pink:TAUG) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC (The Company's previously announced new planned wholly owned subsidiary). The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it's seeking monetary damages in excess of $4,500,000 USD.



NON SOLICITATION:

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.

DISCLAIMER:

Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.

CONTACT: Mr. Seth M. Shaw Chairman & Chief Executive Officer email: sshaw@tauriga.com Cell # (917) 796 9926 Fax # (514) 221 3336

2017 Nasdaq, Inc. All rights reserved.

http://www.marketwatch.com/story/tauriga-sciences-inc-discloses-additional-personal-investment-of-55000-usd-from-its-chief-executive-officer-seth-m-shaw-investment-structured-as-equity-private-placement-priced-at-000125-2017-06-21?siteid=nbsh&mg=prod/accounts-wsj